Risk of relapse after natalizumab withdrawal: Results from the French TYSEDMUS cohort
Papeix, Caroline, Vukusic, Sandra, Casey, Romain, Debard, Nadine, Stankoff, Bruno, Mrejen, Serge, Uhry, Zoe, Van Ganse, Eric, Castot, Anne, Clanet, Michel, Lubetzki, Catherine, Confavreux, Christian, Fontaine, Bertrand, Moreau, Thibault, Brochet, Bruno, Pelletier, Jean, de Seze, Jerome, Cotton, Francois, Dousset, Vincent, Laplaud, David, Debouvery, Marc, Edan, Gilles, Papeix, Caroline, Créange, Alain, Mickaeloff, Yann, deiva, Kumaran, Gout, Olivier, Frenay, Christine Lebrun, vermersch, Patrick, Defer, Giulles, Berger, Eric, Thouvenot, Eric, CabreMD, Philippe, Labauge, Pierre, Camu, William, Bourre, Bertrand, Candessanche, Jean Philippe, Magy, Laurent, Al-Khedr, Abdellatif, Tourbah, Ayman, Casez, Olivier, Guennoc, Anne-Marie, Ciron, Jonathan
Published in Neurology : neuroimmunology & neuroinflammation (01.12.2016)
Published in Neurology : neuroimmunology & neuroinflammation (01.12.2016)
Get full text
Journal Article